BIG
MYGN icon

Brooklyn Investment Group’s Myriad Genetics MYGN Stock Holding History

Brooklyn Investment Group’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.1K Buy
+11,136
New +$58K ﹤0.01% 1819
2025
Q4 		– Sell
-41,155
Closed -$216K – 1540
2025
Q3 		$216K Hold
41,155
– – 0.03% 557
2025
Q2 		$219K Buy
41,155
+40,994
+25,462% +$242K 0.03% 564
2025
Q1 		$1.43K Sell
161
-301
-65% -$3.62K ﹤0.01% 2257
2024
Q4 		$6.33K Buy
+462
New +$8.53K ﹤0.01% 1139

Other funds holding MYGN

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Brooklyn Investment Group's MYGN Position: Q1 2026 in Review

Brooklyn Investment Group opened a new position in Myriad Genetics (MYGN) in Q1 2026: 11,136 shares worth $50.1K. The stake represents ﹤0.01% of the portfolio and ranks #1819 among its holdings. This is a return to the name: Brooklyn Investment Group previously reported a position in MYGN as recently as Q3 2025.

Brooklyn Investment Group first reported a position in MYGN in Q4 2024 and has held it in 5 quarters since. The position peaked at $219K in Q2 2025. 203 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.

  • Brooklyn Investment Group held 11,136 shares of Myriad Genetics worth $50.1K as of Q1 2026.
  • Myriad Genetics was a new Brooklyn Investment Group position in Q1 2026.
  • Myriad Genetics made up ﹤0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1819 holding.
  • Brooklyn Investment Group first reported a position in Myriad Genetics in Q4 2024 and has held it in 5 quarters since.
  • Brooklyn Investment Group's Myriad Genetics position peaked at $219K in Q2 2025.
  • 203 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.